Sectors
SLS
SELLAS Life Sciences Group, Inc.
11.99
1 x 12.00
13 x 12.04
bid
ask
-
0.91
7.05%
10:02 AM
timesize
| Ytd | 218.04% | |
| 1y | 551.63% |
11.98
day range
12.60
1.39
52 week range
15.45
| Open | 12.47 | Prev Close | 12.90 | Low | 11.98 | High | 12.60 | Mkt Cap | 2.40B |
| Vol | 1.45M | Avg Vol | 9.45M | EPS | -0.23 | P/E | -56.09 | Forward P/E | -102.08 |
| Beta | 2.42 | Short Ratio | 6.31 | Inst. Own | 27.82% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-11 | 50-d Avg | 9.76 | 200-d Avg | 5.04 | 1yr Est | 27.50 |
| Income Statement | |||
| Operating Expenses | 9.25M | ||
| Research and Development Expense | 5.13M | ||
| Selling, General and Administrative Expense | 4.12M | ||
| Operating Income | -9.25M | ||
| Net Income | -8.41M | ||
| Net Income Common Stock | -8.41M | ||
| Net Income Common Stock (USD) | -8.41M | ||
| Consolidated Income | -8.41M | ||
| Earnings per Basic Share | -0.05 | ||
| Earnings per Basic Share (USD) | -0.05 | ||
| Earnings per Diluted Share | -0.05 | ||
| Earning Before Interest & Taxes (EBIT) | -8.41M | ||
| Earning Before Interest & Taxes (USD) | -8.41M | ||
| Weighted Average Shares | 172.48M | ||
| Weighted Average Shares Diluted | 172.48M | ||
| Balance Sheet | |||
| Cash and Equivalents | 107.20M | ||
| Cash and Equivalents (USD) | 107.20M | ||
| Current Assets | 111.17M | ||
| Property, Plant & Equipment Net | 839.00K | ||
| Total Assets | 114.18M | ||
| Debt Current | 562.00K | ||
| Total Debt | 871.00K | ||
| Current Liabilities | 6.46M | ||
| Debt Non-Current | 309.00K | ||
| Total Liabilities | 6.77M | ||
| Accumulated Retained Earnings (Deficit) | -283.39M | ||
| Shareholders Equity | 107.41M | ||
| Shareholders Equity (USD) | 107.41M | ||
| Assets Non-Current | 3.01M | ||
| Total Debt (USD) | 871.00K | ||
| Goodwill and Intangible Assets | 1.91M | ||
| Liabilities Non-Current | 309.00K | ||
| Trade and Non-Trade Payables | 3.63M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 153.00K | ||
| Net Cash Flow from Financing | 44.15M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 35.30M | ||
| Issuance (Purchase) of Equity Shares | 44.15M | ||
| Net Cash Flow from Operations | -8.85M | ||
| Share Based Compensation | 798.00K | ||